Antipsychotics and Weight Gain
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
One-third of patients suffering from schizophrenia develop diabetes as a direct result of treatment. In the future, we may be able to use pharmacogenomics to determine which antipsychotic would be the safest for any given patient. Is the future here? Dr Ruaño joins host Dr. Leslie Lundt to discuss his recent work in this area.
Overview
One-third of patients suffering from schizophrenia develop diabetes as a direct result of treatment. In the future, we may be able to use pharmacogenomics to determine which antipsychotic would be the safest for any given patient. Is the future here? Dr Ruaño joins host Dr. Leslie Lundt to discuss his recent work in this area.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
Evaluating Sleep Deprivation as a Risk Factor for Postpartum Depression
Clinical Strategies for Assessing Sleep Disturbances in Postpartum Patients
Reducing the Risk of Postpartum Depression Through Sleep Interventions
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?